Detalhe da pesquisa
1.
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70.
Clin Infect Dis
; 74(8): 1459-1467, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34283213
2.
Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older.
J Infect Dis
; 216(11): 1352-1361, 2017 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29029224